Pineocytoma secondary prevention

Revision as of 18:38, 8 October 2019 by Homa Najafi (talk | contribs) (Created page with "__NOTOC__ {{Pineocytoma}} {{CMG}}{{AE}}{{SR}}{{Homa}} ==Overview== There are no established measures for the secondary prevention of [disease name]. OR Effective measures f...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2] Homa Najafi, M.D.[3]

Overview

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].

Secondary Prevention

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include:

  • [Strategy 1]
  • [Strategy 2]
  • [Strategy 3]

References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Pineocytoma_secondary_prevention&oldid=1583662"